Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Fentanyl Aerosol for Breakthrough Cancer Pain
NCT05531422Phase 2Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Oct 2021
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl in breakthrough cancer pain (BTcP), sponsored by Lee's Pharmaceutical Holdings Limited. Started Oct 2021; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT05531422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05531422.